Charles River Laboratories International Inc.

NYSE:CRL  
403.53
-2.31 (-0.57%)
Divestitures / Spin-offs, Other Pre-Announcement

Charles River Laboratories Announces Two Divestitures

Published: 10/12/2021 23:06 GMT
Charles River Laboratories International Inc. (CRL) - Charles River Laboratories Announces Two Divestitures.
Charles River Laboratories International - Divested Its Research Models and Services Operations in Japan and Its Gene Therapy Cdmo Site in Sweden.completed Sale of Rms Japan Operations to Jackson Laboratory for About $63 Million in Cash.
Charles River- Expects Both Divestitures to Reduce Revenue by Nearly $20 Million and Non-GAAP Diluted Earnings per Share by Nearly $0.10 in Q4 of 2021.
Charles River - Completed Sale of Its Gene Therapy Cdmo Site in Sweden to a Private Investor Group for Approximately $52 Million in Cash.